Simulations Plus Celebrates 25 Years in Business

Division: PBPK

This month marks the 25th anniversary of Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries. In celebration of its achievements, Simulations Plus will host a series of exciting events throughout the year to share the milestones and challenges of the last 25 years while looking ahead to future opportunities.

“We are very proud and humbled by our achievements at SLP over these past 25 years and look forward to celebrating this milestone over the next year with our clients, employees, and collaborators,” said Shawn O’Connor, Chief Executive Officer. “Founded in the mid-nineties by Walt Woltosz with his vision to bring modeling and simulation to the drug development process, we stand 25 years later as a leader in this field that has now achieved industry, scientific, and regulatory acceptance and endorsement. Today, these approaches are being rapidly adopted to significantly improve the time and cost to regulatory approval for the pharmaceutical and biotech communities.”

“We wish to thank our clients, many of whom have been with us since that first release of GastroPlus 23 years ago. We wish to acknowledge our employees and alumni who have contributed to our collective success over the years with a special call-out to our colleagues at Cognigen who began their journey 28 years ago before joining SLP in 2014. And finally, we wish to thank our shareholders who have supported us through these many years since our initial public offering in 1997.”

As Simulations Plus celebrates its 25th anniversary, several initiatives are planned:

  • Simulations Plus will be making charitable contributions of $25,000 to four different organizations throughout 2021-2022. To learn which charities have been selected, follow the company’s LinkedIn page and the hashtag #SLPTurns25
  • Donations to American Forests and Feeding America
  • New website content including redesigned Resource Center, Team Bio pages, and Scientific Case Studies
  • Second Annual Model-Informed Drug Development conference in February 2022

Simulations Plus continues to be excited to offer high quality products and services while providing the best experience for its clients. Learn more about the history of SLP here: https://www.simulations-plus.com/about/